NCT06259162招募中不适用
The Evaluation the Relationship Between LAG-3 Expression / Immune Checkpoint Protein Expression and Neoadjuvant Chemotherapy Plus Immune Checkpoint Inhibitor in Triple Negative Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 128
- 试验地点
- 2
- 主要终点
- LAG-3 expression/immune checkpoint preotein expression
研究概览
简要总结
This study is the experimental study for relationship between LAG-3 expression / immue checkpoint protein expression and neoadjuvant chemotherapy plus immune checkpoint inhibitor in triple negative breast cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Planned neoadjuvant chemotherapy
- •Triple negative breast cancer
排除标准
- •HER2-positive breast cancer
- •Hormone receptor positive breast cancer
结局指标
主要结局
LAG-3 expression/immune checkpoint preotein expression
时间窗: Before chemotherapy, 1 weeks & 3 weeks after chemotherapy, curative surgery
Relationship neoadjuvant chemotherapy plus immune checkpoint inhibitor
次要结局
未报告次要终点
研究者
JI-YEON, KIM
Professor
Samsung Medical Center
研究点 (2)
Loading locations...
相似试验
终止
早期 1 期
Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALLLeukemia, Acute LymphocyticNCT04803123Dorothy Sipkins, MD, PhD3
已完成
不适用
"Galectin-3 as a Marker of Subclinical Inflammation in FMF"Ailesel Akdeniz AteşiNCT06451471Turkish League Against Rheumatism154
Unknown
不适用
FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.Acute Myeloid LeukemiaNCT05383014Assiut University82
已完成
不适用
The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC PatientsCarcinoma, Non-Small-Cell LungNCT02714335Szu-Hua Pan200
尚未招募
不适用
Galectin-3 and oral submucous fibrosisCTRI/2020/12/029928Dr Hetvi Sheth